Covered recipient · General Payments record
ASHLEY BOHLING
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$7,936.34
- Reported across 32 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $2,010.00 | 2 |
| Food and Beverage | $121.35 | 7 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $2,050.37 | 5 |
| REVANCE THERAPEUTICS, INC. | $45.23 | 2 |
| Galderma Laboratories, L.P. | $35.75 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $1,340.00 | 02/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106788662 | CMS |
| ABBVIE INC. | $670.00 | 04/23/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106788666 | CMS |
| ABBVIE INC. | $13.46 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106788670 | CMS |
| ABBVIE INC. | $15.61 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106788674 | CMS |
| ABBVIE INC. | $11.30 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106788678 | CMS |
| Galderma Laboratories, L.P. | $19.39 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145344076 | CMS |
| Galderma Laboratories, L.P. | $16.36 | 12/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145344078 | CMS |
| REVANCE THERAPEUTICS, INC. | $22.35 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147934541 | CMS |
| REVANCE THERAPEUTICS, INC. | $22.88 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147934543 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.